Searching for genes linked to how severe 22q11.2 deletion syndrome becomes
Studies genes tied to severity in 22q11.2 deletion syndrome patients.
Key facts
- Who runs it
- Albert Einstein College of Medicine
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- Jul 2016
- Expected to end
- Jun 2029
- Type of study
- Observational
- Record updated
- 29 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with 22q11.2 deletion syndrome (also called DiGeorge syndrome). It will study their DNA to find genetic changes linked to how severe the disorder is.
- Sex
- All sexes can join.
- Disease stage
- 22q11.2 deletion syndrome with a deletion of 3 megabases (Mb).
- Biomarker or test result
- A 22q11 deletion of 3 megabases (Mb).
Main reasons for not taking part
- A 22q11 deletion smaller than 3 Mb
- No 22q11 deletion
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Has 22q11 deletion of 3 megabases (Mb)
Who cannot take part
- Has 22q11 deletion smaller than 3 Mb or no deletion
Where in United States
- Albert Einstein College Of MedicineNew York, United StatesContact: Bernice E. Morrow, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Genetic Modifiers of 22q11.2 Deletion Syndrome
- Plain-language title
- Searching for genes linked to how severe 22q11.2 deletion syndrome becomesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 29 July 2026